MONTVALE, N.J., Feb. 28 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will report its fourth quarter and full year 2007 financial results on Thursday, March 6, 2008, before the U.S. financial markets open. Management will provide a Company update and discuss the financial results during a conference call on Thursday, March 6, 2008, at 9:00 a.m. EST.
http://www.memorypharma.com
An audio replay of the conference call will be available from 11:00 a.m. EST on Thursday, March 6, 2008, until Thursday, March 13, 2008. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 63677090. An audio replay of the conference call will also be available under the “Investors” section of the Company’s website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer’s disease and, schizophrenia. For additional information, please visit our website at http://www.memorypharma.com.
CONTACT: Jzaneen Lalani, General Counsel, +1-201-802-7249, of Memory
Pharmaceuticals Corp.; or Laura Perry, LMP Investor Relations Inc.,
+1-646-719-1055, for Memory Pharmaceuticals Corp.
Web site: http://www.memorypharma.com/
